Angola vs Mali: HIV positive pregnant women receiving antiretrovirals, using
HIV positive pregnant women receiving antiretrovirals, using over time
- Angola
- Mali
How they compare
Mali currently reports 20.0% against 10.0% in Angola, a difference of 10.0%.
That makes Mali's figure about 2.0 times Angola's.
The two have swapped places 2 times across 5 shared years of data; in 2005 it was Mali ahead.
Angola ranks 32nd and Mali ranks 29th of 38 countries.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.5% | 11.5% | 4.0% | Mali |
| 2010s | 10.0% | 20.0% | 10.0% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv positive pregnant women receiving antiretrovirals, using, Angola or Mali?
- Mali, at 20.0% against 10.0% in Angola as of 2011.
- What is the difference in hiv positive pregnant women receiving antiretrovirals, using between Angola and Mali?
- 10.0%, with Mali ahead.
- How many years of comparable data are there for Angola and Mali?
- 5 years are reported by both, from 2005 to 2011.
- How do Angola and Mali rank globally for hiv positive pregnant women receiving antiretrovirals, using?
- Angola ranks 32nd and Mali ranks 29th of 38 countries.
- Where does this data come from?
- http://data.unaids.org/pub/GlobalReport/2008/, published as HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; low estimate). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission. Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. Denominator: Estimated number of HIV-infected pregnant women in the last 12 months. Ranges are presented for countries with low and concentrated epidemics. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV. All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted. All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum). The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.